Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPB - Cypress BioScience -- Ignore unavailable to you. Want to Upgrade?

To: John S. Baker who wrote (389)	9/16/1998 9:16:00 AM
From: brent gephart	Respond to of 586

All I know is I wish I would have averaged down a little more in recent months since most of my shares are in the mid $2's. I don't think the stock will go up too much today on the news, even thought we all know it should. What ever happens with the exception of a huge jump today the stock is a very good buy considering this release and move up in the RA time frame for potential release. However, regardless of any economic situation related to this news the FDA really needs to get this column approved for the people out there who it will benefit. Brent

To: John S. Baker who wrote (389)	9/16/1998 9:26:00 AM
From: John S. Baker	Respond to of 586

Further confirmation that there was strong buying (accumulation) last week in CYPB: leedomreports.com Key in the stock symbol CYPB and then note the jump last week. For contrast, key in ESSI JSb.